Ian Pike's Biography

Ian Pike, Chief Operating Officer, Proteome Sciences Plc

Dr. Ian Pike is Chief Operating Officer at Proteome Sciences where he leads the Scientific, Commercial and Intellectual Property Functions. Ian has 25 years experience in the diagnostics and biomarker fields. After his PhD and post-doctoral studies Ian joined Wellcome Diagnostics (subsequently Murex Biotech) where he developed and launched three in vitro diagnostic assays for infectious diseases. After 5 years in technology transfer with the UK Medical Research Council and Cancer Research UK where he managed diverse portfolios in neuroscience, infectious diseases and cancer Ian joined Proteome Sciences in 2002.

Post-translational Modification of Proteins - A Rich Source of Pharmacodynamic and Clinical Biomarkers

Tuesday, 8 July 2014 at 16:00

Add to Calendar ▼2014-07-08 16:00:002014-07-08 17:00:00Europe/LondonPost-translational Modification of Proteins - A Rich Source of Pharmacodynamic and Clinical BiomarkersBiomarkers 2014 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

Global and targeted mass spectrometry profiling of post-translational modification of proteins in Alzheimer's disease is providing new insights into disease pathology, response to novel treatments and delivering new diagnostic and prognostic blood biomarkers.

Add to Calendar ▼2014-07-08 00:00:002014-07-09 00:00:00Europe/LondonBiomarkers 2014Biomarkers 2014 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

Conference Sponsors